🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsExercise & Body CompositionCrossFit on tirzepatide — what worked for you? Page 2

CrossFit on tirzepatide — what worked for you?

labquiet_amy Sat, Jul 12, 2025 at 2:25 AM 49 replies 2,245 viewsPage 2 of 10
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Jul 12, 2025 at 4:35 AM#6
DataDave said:
Steady state is faster than people expect: half-life about five days, so you are at plateau in roughly three to four weeks rather than five.

I read this differently from DataDave, on substance rather than tone. The "tirzepatide is simply better" summary irritates me. It is better on mean weight loss, and the cardiovascular outcome evidence is far thinner than semaglutide's. If the reason for treating is cardiovascular risk rather than weight, the evidence base points the other way.

41 11mike_nyc, VendorMark, COA_Karl and 38 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Jul 12, 2025 at 5:25 AM#7

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

40 10Dr.ObesityLA, NurseKim_ATL, paul_denver and 37 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Jul 12, 2025 at 6:15 AM#8
Dr.GastroMayo said:
The "tirzepatide is simply better" summary irritates me.

Coming at Dr.GastroMayo’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

39 9wanda_boise, NurseAsh_DET, BenResearch_OR and 36 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Jul 12, 2025 at 7:05 AM#9

Following on from mia_MS2 — and this may be the naive question:

How much of the tirzepatide advantage is the GIP component and how much is simply that the dose ladder goes higher in receptor-occupancy terms?

38 8patPC_UT, Dr.DermMIA, fiona_VT and 35 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jul 12, 2025 at 11:04 AM#10

Closing the loop on my own question.

Reporting back after another eight months at the same dose. Still losing slowly, no new side effects, and no reason I can find to climb further.

28 1pete_manc_UK, anna.melb_AU, mark_tokyo and 25 others
Reply Quote Save Share Report

Similar Threads

Resistance training prevents 73% lean mass loss on semaglutide — RCT review11 replies
DEXA scan longitudinal data — 12 months on GLP-1 + lifting18 replies
Zone 2 cardio + GLP-1: synergistic metabolic benefits — evidence18 replies
Creatine kinase elevations on GLP-1 — exercise-induced or concerning?14 replies
Body recomposition protocol: GLP-1 + progressive overload + high protein8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register